期刊文献+

新型抗凝血药替格瑞洛的合成 被引量:10

Synthesis of Novel Anticoagulant Ticagrelor
下载PDF
导出
摘要 目的高效合成抗凝血药替格瑞洛。方法 4,6-二氯-2-(丙硫基)-5-硝基嘧啶在铁粉、乙酸作用下还原后与2-(((3aR,4S,6R,6a S)-6-氨基-2,2-二甲基四氢-3a H-环戊〔d〕〔1,3〕二氧杂-4-基)氧基)乙醇经C-N偶联、重氮化成环,再与(1R,2R)-2-(3,4-二氟苯基)环丙胺亲核取代,最后酸解脱丙叉基保护得到替格瑞洛。结果与结论目标化合物的总收率约为55%,结构经1H NMR和MS确证。该合成路线反应步骤少,操作简便,反应条件温和,收率高,适合工业化生产。 OBJECTIVE To Develop a highly-efficient synthesis method for anticoagulant ti-cagrelor.METHODS 4,6-Dichloro-2-(propylthio)pyrimidin-5-aminewasreducedintoaminocompoundviairon powder and acetic acid,and after the C-N cross-coupling and diazotization into the ring with 2-(((3aR,4S,6R, 6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta〔d〕〔1,3〕dioxol-4-yl) oxy) ethanol,which was followed by nu-cleophilic substitution with (1R,2R)-2-(3,4-difluoro) cyclopropanamine and isopropylidene deprotection to provide ticagrelor.RESULTS and CONCLUSION The target compound was obtained in about 55%overall yield,and the chemical structure was confirmed by 1H NMR and MS.The developed method has some advantages such as few reac-tion steps,ease operations,mild reaction conditions,high yield,and suitable for industrial production.
出处 《海峡药学》 2015年第4期249-251,共3页 Strait Pharmaceutical Journal
关键词 化学合成 替格瑞洛 抗凝血药 Chemical synthesis Ticagrelor Anticoagulant
  • 相关文献

参考文献6

二级参考文献41

  • 1Owen RT,Serradell N,Bolos J.AZD6140[J].Drugs Future,2007,32 (10):845-853.
  • 2Hardern D,Ingall A,Springthorpe B,et al.Triazolo (4,5-d)pyrimidine compounds:US,6525060[P].2003-02-25.
  • 3Larsson U,Magnusson M,Musil T,et al.Novel triazolo pyrimidine compounds:US,2003148888[P].2003-08-07.
  • 4Just G,Cutrone L.2,3-Oxazabicyclo[2.2.1] heptane[J].Can J Chem,1976,54:867-870.
  • 5Jung M,Offenbacher G,Retey J.Total synthesis of neplanocin A[J].Helv Chim Acta,1983,66(7):1915-1921.
  • 6Welch JT,Lin J.Fluoroolefin containing dipeptide isosteres as inhibitors of dipeptidyl peptidase IV (CD26)[J].Tetrahedron,1996,52 (1):291 -304.
  • 7Ahlford K,Zaitsev AB,Ekstrom J,et al.A simple and efficient catalyst system for the asymmetric transfer hydrogenation of ketones[J].Synlett,2007,16:2541-2544.
  • 8Shireman BT,Miller MJ.Rapid syntheses of either enantiomer of important carbocyclic nucleoside precursors[J].Tetrahedron Lett,2000,41 (49):9537-9540.
  • 9Ranganathan S,George KS.2-Aza-3-oxabicyclo[2.2.1] heptene hydrochloride:an exceptionally versatile synthon for carbocyclic sugars and nucleosides[J].Tetrahedron,1997,53 (9):3347-3362.
  • 10Springthorpe B,Bailey A,Barton P,et al.From ATP to AZD6140:the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis[J].Bioorg Med Chem Lett,2007,17 (21):6013-6018.

共引文献12

同被引文献61

  • 1薛娜,张恺,杜玉民,刘伟娜.手性药物的药理学及其分离测定研究进展[J].河北医科大学学报,2009,30(7):753-756. 被引量:3
  • 2李根容,李志良.手性药物拆分技术研究进展[J].中国新药杂志,2005,14(8):969-974. 被引量:16
  • 3翁文,姚碧霞,陈秀琴,陈友遵,林文士,曾庆乐.液相色谱手性拆分机理的热力学方法研究[J].化学进展,2006,18(7):1056-1064. 被引量:26
  • 4Simon. The invention provides new triazolo [ 4,5-d ] py- rimidine compounds of formula (I) , their use as medic- aments, compositions containing them and processes for their preparation:WO 990143 [ P]. 1999.
  • 5Ulf Larsson, Magnusson, Musil, et al. Novel triazolo pyrimidine compounds : US 20030148888 [ P]. 2003.
  • 6Anil S K, Vignesh N, Nikhil T. Improved process for preparing eyelopentylamine derivatives and intermedi-ates thereof: WO 2012172426 [ P 3. 2012.
  • 7David H, Anthony I, Brian S, et al. Triazolo (4,5-D) pyrimi- dine : US 6525060 E P]. 2003.
  • 8Zhang H, lJu J, Zhang L Y, et a/. Synthesis and biological e- valuation of cyclopentyl-triazolo- pyrimidine derivatives as novel antiplatelet agents[ J ]. Bioorgan- ic & Medicinal Chemistry Let- ters,2012,~'~( 11 ) :3598 - 3602.
  • 9胡晨阳,任芳俊,盛晓霞,等.替格瑞洛晶型及其制备方法和用途:CN201310118496.8[P].2013.
  • 10M·博林,S·科斯格洛夫,B·拉森.三唑并[4,5.D]嘧啶化合物的新晶形和非晶形:CN01810582.3[P].2001.

引证文献10

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部